---
title: "Kerala Ayurveda Ltd (530163) — Share Price, Financials & Analysis"
symbol: "530163"
company: "Kerala Ayurveda Ltd"
canonical: "https://tapetide.com/stocks/530163"
isin: "INE817B01025"
nse_symbol: "KERALAAYURVEDALTD"
bse_code: "530163"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 228.66
generated_at: "2026-09-13T18:51:21.537Z"
---

# Kerala Ayurveda Ltd (530163)

Canonical page: https://tapetide.com/stocks/530163

## Company

- **NSE Symbol:** KERALAAYURVEDALTD
- **BSE Code:** 530163
- **ISIN:** INE817B01025
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** keralaayurveda.biz

## About

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:04.212812Z.

- **Market Cap:** ₹228.66 Cr
- **Classification:** Microcap
- **P/E (reported):** -8.7
- **EPS (TTM):** ₹-21.06
- **EPS (reported):** ₹0
- **Book Value:** ₹8.79
- **Price to Book:** 20.1
- **Dividend Yield:** 0%
- **ROE:** -108.29%
- **ROCE:** -19.98%
- **Debt to Equity:** 7.82
- **Revenue (yearly):** ₹131.15 Cr
- **Net Income:** ₹-16.32 Cr
- **EBITDA:** ₹-17.75 Cr
- **52-Week High:** ₹503.9
- **52-Week Low:** ₹145
- **RSI (14):** 54.45

## Tapetide Score

- **Score:** 30 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 2 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 14.01 | 9% |
| growth | 54.45 | 9% |
| momentum | 19.95 | 12% |
| ownership | 50 | 24% |
| quality | 15.36 | 22% |
| valuation | 21.34 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Debtor days have improved from 51.1 to 38.4 days.

### Weaknesses

- Stock is trading at 20.4 times its book value
- Company has low interest coverage ratio.
- Promoter holding is low: 35.6%
- Company has a low return on equity of -85.2% over last 3 years.
- Promoter holding has decreased over last 3 years: -25.9%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 603.13% | -51.01% | -34.99% |
| ebitda margin growth | 30.77% | 369.62% | -242.97% | -201.24% |
| net income growth | -9.46% | 16.57% | — | -780% |
| revenue growth | -8.99% | 7.32% | 12% | 16% |
| roce | -20.93% | -245.84% | -396.44% | 3.71% |
| roe | 9.19% | — | -38.78% | 16.34% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 25.03 | 26.32 | 32.03 | 27.47 | 30.41 | 31.13 | 31.32 | 28.61 | 34.84 | 32.96 | 34.74 | 33.19 |
| Expenses | 24.49 | 25.31 | 26.58 | 26.67 | 24.88 | 32.32 | 41.46 | 32.8 | 39.79 | 34.47 | 41.84 | 37.02 |
| Operating Profit | 0.54 | 1.01 | 5.45 | 0.8 | 5.53 | -1.19 | -10.14 | -4.19 | -4.95 | -1.51 | -7.1 | -3.83 |
| OPM % | 2.16 | 3.84 | 17.02 | 2.91 | 18.18 | -3.82 | -32.38 | -14.65 | -14.21 | -4.58 | -20.44 | -11.54 |
| Other Income | 0.77 | 0.23 | -0.86 | 0.22 | 0.64 | 0.23 | 0.73 | 9.47 | 1.7 | 1.13 | 1.91 | 0.26 |
| Interest | 0.65 | 0.61 | 3.26 | 0.46 | 0.72 | 0.43 | 2.48 | 0.82 | 2.58 | 2.84 | 1.1 | 2.79 |
| Depreciation | 0.32 | 0.34 | 1.15 | 0.36 | 1.98 | 0.72 | 1.92 | 1.65 | 0.99 | 1.15 | 1.69 | 1.87 |
| Profit before tax | 0.34 | 0.29 | 0.18 | 0.2 | 3.47 | -2.11 | -13.81 | 2.81 | -6.82 | -4.37 | -7.98 | -8.23 |
| Tax % | 100 | 368.97 | -194.44 | -125 | -4.9 | 27.96 | 11.3 | 27.76 | -6.74 | 5.26 | -7.39 | -1.82 |
| Net Profit | 0 | -0.79 | 0.53 | 0.46 | 3.65 | -2.7 | -15.38 | 2.03 | -6.36 | -4.6 | -7.39 | -8.08 |
| EPS in Rs | -0.12 | -0.9 | 0.22 | 0.27 | 2.84 | -2.4 | -12.92 | 1.65 | -5.26 | -3.69 | -5.97 | -6.14 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 59 | 59 | 77 | 62 | 80 | 93 | 108 | 126 | 131 | 136 |
| Expenses | 51 | 54 | 69 | 61 | 71 | 91 | 100 | 131 | 149 | 153 |
| Operating Profit | 8 | 5 | 7 | 1 | 10 | 3 | 9 | -5 | -18 | -17 |
| OPM % | 14 | 9 | 10 | 1.4 | 12 | 2.8 | 8 | -4 | -14 | -13 |
| Other Income | 0 | 1 | 0 | 0 | 1 | 3 | 0 | 2 | 14 | 5 |
| Interest | 2 | 3 | 2 | 6 | 7 | 5 | 6 | 4 | 7 | 9 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 6 |
| Profit before tax | 4 | 3 | 5 | -7 | 3 | -1 | 1 | -12 | -16 | -27 |
| Tax % | 31 | 19 | 11 | -28 | 15 | -23 | 185 | 14 | 0 | — |
| Net Profit | 3 | 3 | 4 | -5 | 2 | 0 | -1 | -14 | -16 | -26 |
| EPS in Rs | 2.66 | 2.31 | 3.69 | -4.59 | 2.24 | -0.85 | -0.47 | -11.6 | -12.74 | -21.06 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 13 |
| Reserves | -4 | -3 | -7 | -3 | -7 | -4 | -5 | 7 | -3 | -2 |
| Borrowings | 56 | 75 | 62 | 64 | 77 | 70 | 72 | 76 | 71 | 86 |
| Other Liabilities | 17 | 20 | 27 | 31 | 34 | 34 | 37 | 38 | 49 | 41 |
| Total Liabilities | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 133 | 129 | 138 |
| Fixed Assets | 34 | 32 | 33 | 33 | 33 | 44 | 46 | 41 | 47 | 50 |
| CWIP | 6 | 11 | 12 | 14 | 14 | 4 | 7 | 7 | 9 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 41 | 59 | 47 | 56 | 68 | 62 | 61 | 85 | 73 | 81 |
| Total Assets | 81 | 103 | 92 | 103 | 114 | 110 | 115 | 133 | 129 | 138 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4 | -10 | 12 | 5 | 7 | 0 | 10 | -1 | 5 | -24 |
| Cash from Investing Activity | -3 | -3 | -3 | -4 | -1 | -2 | -7 | 0 | -15 | -5 |
| Cash from Financing Activity | 0 | 17 | -12 | 1 | 6 | -13 | -2 | 20 | -9 | 32 |
| Net Cash Flow | 1 | 4 | -2 | 2 | 12 | -16 | 0 | 18 | -19 | 3 |
| Free Cash Flow | 3 | -16 | 10 | 2 | 6 | -3 | 4 | -2 | -8 | -30 |
| CFO/OP | 62 | -120 | 251 | 71 | 885 | -5 | 390 | 1 | -138 | 136 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 35 | 34 | 43 | 51 | 61 | 61 | 51 | 59 | 56 | 38 |
| Inventory Days | 319 | 338 | 311 | 313 | 268 | 254 | 227 | 205 | 208 | 200 |
| Days Payable | 112 | 125 | 117 | 162 | 149 | 168 | 137 | 114 | 93 | 129 |
| Cash Conversion Cycle | 242 | 247 | 236 | 202 | 179 | 147 | 141 | 149 | 171 | 109 |
| Working Capital Days | -213 | -63 | -24 | -19 | -99 | -118 | -81 | -172 | -147 | -162 |
| ROCE % | 9 | 9 | 6 | 9 | 0 | 11 | 2 | 8 | -9 | -10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 61.52% | 63.44% | 58.58% | 58.58% | 58.58% | 58.58% | 58.58% | 37.83% | 33.14% | 33.14% | 35.61% | 35.61% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.22% | 0.17% | 0.17% |
| DIIs | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 27.04% | 28.91% | 31.58% | 32.25% | 32.24% | 32.19% | 32.23% | 41.26% | 44.36% | 44.42% | 42.16% | 42.02% |
| Others | 11.4% | 7.6% | 9.8% | 9.13% | 9.14% | 9.2% | 9.15% | 20.87% | 22.46% | 22.18% | 22.03% | 22.17% |
| No. of Shareholders | 7855 | 8428 | 8581 | 8655 | 9052 | 9009 | 9074 | 9401 | 9938 | 9952 | 10184 | 10372 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 7 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 173.37 | Buy |
| EMA (10) | 175.5 | Sell |
| SMA (20) | 179.85 | Sell |
| EMA (20) | 174.67 | Sell |
| SMA (50) | 168.25 | Buy |
| EMA (50) | 174.75 | Sell |
| SMA (100) | 183.6 | Sell |
| EMA (100) | 188.43 | Sell |
| SMA (200) | 223.2 | Sell |
| EMA (200) | 230.23 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.2 | Neutral |
| MACD (12,26,9) | 1.42 | Sell |
| Stochastic (14,3,3) | 51.11 | Neutral |
| ADX (14) | 14.92 | Neutral |
| Williams %R (14) | -48.24 | Neutral |
| ATR (14) | 10.33 | High Volatility |
| ROC (12) | -3.73 | Sell |
| Stoch RSI (14) | 45.94 | Neutral |
| UO (7,14,28) | 46.33 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5fed8f4-8afa-4db5-8e14-e96ceabeb1ee.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=244e302f-306e-460f-bc13-daf4bd7e2f8c.pdf) |
| 2026-09-05 | [Notice Of 34Th Annual General Meeting Of Kerala Ayurveda Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df9d4d39-f006-4aa4-9474-536ae3935db4.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Preferential Issue](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2caafbdc-29a3-4758-af20-950c3c6c6dc2.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8058d11d-891a-4bca-bb2d-ca73594c989c.pdf) |
| 2026-09-01 | [Board Meeting Intimation for Preferential Issue Of Shares And Intimation About AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8de332-cb1f-47f0-8e4a-483bbc799f9a.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5bf6d04-a4d3-46ee-8955-d11357b2bf45.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting 12Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26ea5a8e-7302-4114-99df-0b28d3854048.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b321bbe1-48f9-4a2a-b3de-78792f46d0ec.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=306ecf93-8d94-41d8-a3b4-3144f384637c.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Results-Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9e30601-a0f3-4707-ba6c-d4ffc7bbc736.pdf) |
| 2026-05-25 | [Results - Financial Results For The Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=206bc601-18ad-42f4-8889-775751e63a72.pdf) |
| 2026-02-12 | [Financial Results For The Quarter Ended 31St December2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dce70664-404f-4531-8979-ec3f299746f4.pdf) |
| 2025-11-14 | [Financial Results For The Quarter Ended 30Th Sept.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62daab48-2aa0-4bba-a55d-250ddbd729d5.pdf) |
| 2025-07-18 | [Integrated Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3c72f7d-db2f-4af7-9b13-57b7b0597e71.pdf) |
| 2025-05-27 | [Financial Results For The Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11899c89-4f43-4d38-b27d-12ec3914224e.pdf) |
| 2025-02-14 | [Financial Results For The Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16b0e1f3-0090-4ead-8552-be5cf2e8c28c.pdf) |
| 2024-11-15 | [Financial Results Q2 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f38ce9a7-12ce-41e6-921b-0268ebfabb9a.pdf) |
| 2024-09-04 | [Unaudited Financial Results Signed By Whole Time Director](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92bd19aa-20d4-4ca9-905b-f73410fbeef9.pdf) |
| 2024-08-14 | [Financial Results For The Quarter Ended 30Th June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a5be626-8932-467f-91f0-8233b3fa8180.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Kerala Ayurveda says share price movement is market-driven and no material information is pending. | [Clarification On Price Movement 8 Apr - Kerala Ayurveda says share price movement is market-driven and no material information is pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/daa7211b-33e1-4c75-9e56-6f135bea9b38.pdf) |
| 6 March 2026 - Management to meet analysts/institutional investors on 11 March 2026, 9:00–17:00, organized by Vivro Financial. | [Analysts/Institutional Investor Meet/Con. Call Updates 6 March 2026 - Management to meet analysts/institutional investors on 11 March 2026, 9:00–17:00, organized by Vivro Financial.](https://nsearchives.nseindia.com/corporate/GANESHINFRA_06032026170521_Concall_letter_to_SE_11032026_-s.pdf) |
| 6 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed7c8612-a767-47b2-8fda-cc7c7401cb3e.pdf) |
| 31 January 2026 - Q3 FY26: Revenue ₹215.3 Cr, PAT ₹19.0 Cr; 9M revenue ₹606.0 Cr; ₹2,211.7 Cr order book; new 51% JV | [Investor Presentation 31 January 2026 - Q3 FY26: Revenue ₹215.3 Cr, PAT ₹19.0 Cr; 9M revenue ₹606.0 Cr; ₹2,211.7 Cr order book; new 51% JV](https://nsearchives.nseindia.com/corporate/GANESHINFRA_31012026163452_IP_Letter_31012026-s.pdf) |
| 30 January 2026 - Board approved unaudited Q3 and 9M results (Dec 31, 2025): Q3 revenue Rs21,633.72 lakhs; 9M PAT Rs5,177.58 lakhs. | [Outcome of Board Meeting 30 January 2026 - Board approved unaudited Q3 and 9M results (Dec 31, 2025): Q3 revenue Rs21,633.72 lakhs; 9M PAT Rs5,177.58 lakhs.](https://nsearchives.nseindia.com/corporate/GANESHINFRA_30012026202351_NSE_Outcome-30012026-s.pdf) |
| 29 January 2026 - Crisil assigned Crisil BBB+/Stable and A2 to Ganesh Infraworld's Rs196 crore bank facilities on Jan 28, 2026. | [Credit Rating 29 January 2026 - Crisil assigned Crisil BBB+/Stable and A2 to Ganesh Infraworld's Rs196 crore bank facilities on Jan 28, 2026.](https://nsearchives.nseindia.com/corporate/GANESHINFRA_29012026184327_Credit_rating_letter_-29012026-s.pdf) |
| 27 Apr - Kerala Ayurveda says SEBI large-corporate debt framework is not applicable; outstanding borrowing was Rs.70.47 crore on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 27 Apr - Kerala Ayurveda says SEBI large-corporate debt framework is not applicable; outstanding borrowing was Rs.70.47 crore on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dcf65297-1d2e-4dab-8bbb-8e76dbbcb7f0.pdf) |
| 26 Mar - Trading window closed March 31, 2026 until 48 hours after audited FY2026 results announcement. | [Closure of Trading Window 26 Mar - Trading window closed March 31, 2026 until 48 hours after audited FY2026 results announcement.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b91831ae-9f63-4839-b403-71bb93988059.pdf) |
| 25 Mar - Board approved private placement of 4,000 NCDs totaling Rs40 crore; 12% p.a., 24-month moratorium, 32 quarterly installments. | [Board Meeting Outcome for Outcome Of Board Meeting 25 Mar - Board approved private placement of 4,000 NCDs totaling Rs40 crore; 12% p.a., 24-month moratorium, 32 quarterly installments.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1014cb04-8e98-4a5e-b3b8-103718794114.pdf) |
| 21 Mar - Board on 25 Mar 2026 to consider issuing secured NCDs up to Rs.40 crore; trading window closed. | [Board Meeting Intimation for The Proposal For Fund Raising By Way Of Issue Of Unlisted, Secured, Redeemable Non-Convertible Debentures For A Value Upto Rs. 40 Crores To Be Held On 25 March 2026. 21 Mar - Board on 25 Mar 2026 to consider issuing secured NCDs up to Rs.40 crore; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/111a7801-eb6c-44c9-93a5-68bc70be2b69.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/GANESHINFRA_22112025130222_transcript_letter-s.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d950f877-f010-4f5b-b46b-2090bbb7b9eb.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/d950f877-f010-4f5b-b46b-2090bbb7b9eb.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/GANESHINFRA_03052025115351_Letter.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://nsearchives.nseindia.com/corporate/GANESHINFRA_24032025191137_IP.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://nsearchives.nseindia.com/corporate/GANESHINFRA_25072025205259_letter_to_se_25072025.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://nsearchives.nseindia.com/corporate/GANESHINFRA_11022025151414_Investor_Presentation.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://nsearchives.nseindia.com/corporate/GANESHINFRA_14022025215113_Transcript_letter_to_SE.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26453_GANESHIN_2024_2025_A_26052025221525.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/441ff7e8-99cc-4394-8855-b0721dc32bca.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca088c56-f9b7-4428-a551-54d5760166c6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b4937413-4b08-4176-a432-de0efbcad84b.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/530163/76438530163.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/530163/72426530163.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/530163/67137530163.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/530163/5301630319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/530163/5301630318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/530163/5301630317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:51:21.537Z.